Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check3 days agoChange Detected- The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a version update to the page; no user-facing study content appears to have changed.SummaryDifference0.0%

- Check10 days agoChange DetectedCertification/Extension metadata was added and two study documents—Study Protocol (11.15 MB) and Statistical Analysis Plan (3.4 MB)—were added to the Study Documents, while older entries from 2026 May–June were removed.SummaryDifference1%

- Check17 days agoChange DetectedThe study record revision was updated to v3.6.6 from v3.6.5, indicating a recent metadata update to the page. The update does not alter the study content or user-visible details.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a minor version bump in the page’s revision history. This appears to be maintenance-oriented and does not change the study content or outcomes.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a deployment/upgrade of the Study Details page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a newer version of the study record. This reflects a metadata update rather than a modification to study details or content visible to users.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.